1 Product identity
Ingredient risk
Contains restricted ingredients
OsteoCare
BrandHimalaya→Other Combinations Capsule 9 ingredients 1 banned DSLD #40509Net contents: 120 Vegetarian Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2014-12-29
2 Ingredients (9)
IngredientGroupSafety
Proprietary BlendProprietary Blend (Combination)—
Gypsum calxGypsum—
Greater GangalGreater galangal—
Indian AbutilonIndian mallow—
ArjunaTerminalia—
Vegetable CelluloseCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha 🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Guggul — Limited Evidence
⚠ GI upset, headache
⚠ Thyroid stimulation
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID40509
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2014-12-29
6 More from Himalaya
View Himalaya Safety Scorecard → 24 products
CoughCare for Mucosal ComfortDiarCareGlucoCareGotu KolaHemoCareKoflet7 Cite this page
Vancouver
Pkhakadze G. OsteoCare — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 24]. Available from: https://supplement.ge/products/osteocare-40509/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG